Neonatal hypoxic-ischemic encephalopathy (NHIE) is a devastating condition for which effective therapeutic treatments are still unavailable. Cannabinoids emerge as neuroprotective substances in adult animal studies; therefore, we aimed herein to test whether cannabinoids might reduce brain damage induced by hypoxiaischemia (HI) in newborn rats. Thus, 7-d-old Wistar rats (P7) were exposed to 8% O 2 for 120 min after left carotid artery ligature, then received s.c. vehicle (VEH) (HIϩVEH), the cannabinoid agonist WIN55212 (WIN) (0.1 mg/kg), or WIN with the CB 1 or CB 2 receptor antagonist SR141617 (SR1) (3 mg/kg) or SR141588 (SR2) (2 mg/kg). Brain damage was assessed by magnetic resonance imaging (MRI) at 1, 3, and 7 d after the insult. At the end of the experiment, MRI findings were corroborated by histology (Nissl staining). HIϩVEH showed an area of cytotoxic and vasogenic edema at 24 h after the insult, then evolving to necrosis. HIϩWIN showed a similar damaged area at 24 h after the insult, but the final necrotic area was reduced by 66%. Coadministration of either SR1 or SR2 reversed the effects of WIN. N HIE remains as a prevalent condition, inducing devastating brain injury leading to death or long-lasting sequelae (1,2). Despite recent progress in neonatology, the incidence of NHIE is not decreasing, likely because the complex pathophysiology of NHIE demands combined therapies or the use of treatments acting at different levels, as hypothermia (1,(3)(4)(5). In addition, due to the current inability to predict accurately perinatal asphyxia, only a posteriori treatments are feasible (1,2).Cannabinoids and their receptors constitute an endogenous system involved, for instance, in the control of synaptic transmission, memory modulation, motivation, movement, nociception, appetite, and thermoregulation (6,7). Two cannabinoid receptors present in the brain have been cloned so far: CB 1 receptors are expressed primarily by neurons but can also be found in glial cells; CB 1 receptors are Gi/o proteincoupled receptors that modulate the activity of several plasma membrane proteins and intracellular signaling pathways (7,8). CB 2 receptors are also Gi/o protein-coupled receptors; although it is accepted that CB 2 receptors are not expressed in forebrain neurons, they have been described in activated glia (8 -10). Lately, cannabinoids are emerging as valuable neuroprotective agents in models of acute and chronic neurodegenerative conditions (6,7,11-15), which may also affect the immature rat brain (16).Due to this evidence, we decided to test whether cannabinoids might be useful for decreasing brain damage in NHIE. For this purpose, we used the Rice-Vannucci model (17), an in vivo model that closely mimics actual NHIE conditions. Importantly, we assessed the effect of WIN when administered after the onset of the HI insult. To evaluate brain damage, we used MRI, an approach with several advantages: (1) MRI allows the development of imaging-based longitudinal studies, providing important data on the response tim...